PTH holdings

All 61 positions of Invesco Exchange-Traded Fund Trust Invesco Dorsey Wright Healthcare Momentum ETF.

Download CSV

Positions

Top 10 weight

32.4%

Effective holdings

45.9

1 / sum of squared weights

In stocks

100.3%

In bonds

0.0%

Outside the US

7.4%

Asset mix

Equity100.3%
Cash32.0%

Sectors

100% of stocks classified

Health Care100.3%

Countries

United States93.0%
Bermuda4.7%
Ireland1.9%
Cayman Islands0.8%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	Invesco Private Prime Fund	Cash	22.92%	$28M	27,706,338	US
2	Invesco Private Government Fund	Cash	8.83%	$11M	10,675,160	US
3	PRAXPraxis Precision Medicines, Inc. Common Stock	Equity	5.08%	$6.1M	19,267	US
4	ROIVRoivant Sciences Ltd. Common Shares	Equity	4.65%	$5.6M	197,099	BM
5	UTHRUnited Therapeutics Corp	Equity	3.43%	$4.2M	7,268	US
6	THCTenet Healthcare Corporation New	Equity	3.04%	$3.7M	20,745	US
7	TERNTerns Pharmaceuticals, Inc. Common Stock	Equity	2.86%	$3.5M	65,368	US
8	TNGXTango Therapeutics, Inc.	Equity	2.85%	$3.4M	159,490	US
9	HCAHCA Healthcare, Inc.	Equity	2.78%	$3.4M	7,728	US
10	AXSMAxsome Therapeutics, Inc	Equity	2.64%	$3.2M	15,385	US
11	NKTRNektar Therapeutics	Equity	2.57%	$3.1M	36,570	US
12	CELCCelcuity Inc. Common Stock	Equity	2.53%	$3.1M	25,182	US
13	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	2.37%	$2.9M	38,394	US
14	CAPRCapricor Therapeutics Inc	Equity	2.26%	$2.7M	81,402	US
15	CORCencora, Inc.	Equity	2.25%	$2.7M	8,829	US
16	ALMSAlumis Inc. Common Stock	Equity	2.12%	$2.6M	103,872	US
17	GILDGilead Sciences Inc	Equity	1.99%	$2.4M	18,363	US
18	KODKodiak Sciences Inc Common Stock	Equity	1.99%	$2.4M	55,223	US
19	BTSGBrightSpring Health Services, Inc. Common Stock	Equity	1.98%	$2.4M	49,825	US
20	JAZZJazz Pharmaceuticals, Inc.	Equity	1.92%	$2.3M	11,426	IE
21	MRNAModerna, Inc. Common Stock	Equity	1.90%	$2.3M	50,080	US
22	PTGXProtagonist Therapeutics, Inc	Equity	1.90%	$2.3M	23,165	US
23	VTRSViatris Inc. Common Stock	Equity	1.88%	$2.3M	152,008	US
24	DNTHDianthus Therapeutics, Inc. Common Stock	Equity	1.80%	$2.2M	24,726	US
25	ANABAnaptysBio, Inc. Common Stock	Equity	1.78%	$2.1M	32,708	US
26	ENSGThe Ensign Group, Inc.	Equity	1.73%	$2.1M	11,223	US
27	INCYIncyte Genomics Inc	Equity	1.71%	$2.1M	21,763	US
28	ERASErasca, Inc. Common Stock	Equity	1.71%	$2.1M	194,096	US
29	LGNDLigand Pharmaceuticals Inc.	Equity	1.62%	$2.0M	8,520	US
30	ORKAOruka Therapeutics, Inc. Common Stock	Equity	1.60%	$1.9M	28,323	US
31	CGONCG Oncology, Inc. Common stock	Equity	1.55%	$1.9M	28,115	US
32	TYRATyra Biosciences, Inc. Common Stock	Equity	1.54%	$1.9M	53,591	US
33	SLSSELLAS Life Sciences Group, Inc. Common Stock	Equity	1.50%	$1.8M	367,216	US
34	SYRESpyre Therapeutics, Inc. Common Stock	Equity	1.49%	$1.8M	24,120	US
35	KYMRKymera Therapeutics, Inc. Common Stock	Equity	1.46%	$1.8M	21,835	US
36	TWSTTwist Bioscience Corporation Common Stock	Equity	1.45%	$1.8M	30,064	US
37	LQDALiquidia Corporation Common Stock	Equity	1.42%	$1.7M	43,673	US
38	BKDBrookdale Senior Living, Inc.	Equity	1.41%	$1.7M	118,923	US
39	AXGNAxogen, Inc. Common Stock	Equity	1.37%	$1.7M	38,310	US
40	EXELExelixis Inc	Equity	1.33%	$1.6M	36,251	US
41	EWTXEdgewise Therapeutics, Inc. Common Stock	Equity	1.31%	$1.6M	51,209	US
42	TRVITrevi Therapeutics, Inc. Common Stock	Equity	1.30%	$1.6M	114,114	US
43	CYTKCytokinetics Inc.	Equity	1.19%	$1.4M	22,459	US
44	ELANElanco Animal Health Incorporated Common Stock	Equity	1.16%	$1.4M	62,951	US
45	RLAYRelay Therapeutics, Inc. Common Stock	Equity	1.13%	$1.4M	105,574	US
46	DYNDyne Therapeutics, Inc. Common Stock	Equity	1.12%	$1.4M	77,358	US
47	PCVXVaxcyte, Inc. Common Stock	Equity	1.12%	$1.4M	23,663	US
48	KRYSKrystal Biotech, Inc. Common Stock	Equity	1.10%	$1.3M	5,073	US
49	ELVNEnliven Therapeutics, Inc. Common Stock	Equity	1.07%	$1.3M	31,343	US
50	RCUSArcus Biosciences, Inc.	Equity	0.94%	$1.1M	44,685	US
51	ANNXAnnexon, Inc. Common Stock	Equity	0.92%	$1.1M	188,931	US
52	STOKStoke Therapeutics, Inc. Common Stock	Equity	0.91%	$1.1M	33,715	US
53	PAHCPhibro Animal Health Corporation Class A	Equity	0.90%	$1.1M	20,545	US
54	MLTXMoonLake Immunotherapeutics Class A Ordinary Shares	Equity	0.79%	$952K	58,091	KY
55	BIOABioAge Labs, Inc. Common Stock	Equity	0.77%	$933K	55,347	US
56	SNDXSyndax Pharmaceuticals, Inc.	Equity	0.73%	$879K	41,013	US
57	CATXPerspective Therapeutics, Inc.	Equity	0.67%	$809K	207,471	US
58	ZBIOZenas BioPharma, Inc. Common Stock	Equity	0.63%	$767K	39,681	US
59	VRDNViridian Therapeutics, Inc. Common Stock	Equity	0.58%	$702K	52,099	US
60	MAZEMaze Therapeutics, Inc. Common Stock	Equity	0.51%	$613K	23,066	US
61	Invesco Government & Agency Portfolio	Cash	0.27%	$322K	322,236	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Exit	GHGuardant Health, Inc.	4.45%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	ARWRArrowhead Pharmaceuticals, Inc.	4.18%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	NTRANatera, Inc.	3.55%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	RVMDRevolution Medicines, Inc.	3.31%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	TNGXTango Therapeutics Inc.	—	2.85%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	MEDPMedpace Holdings, Inc.	2.81%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	NKTRNektar Therapeutics	—	2.57%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	BBIOBridgeBio Pharma, Inc.	2.51%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	IONSIonis Pharmaceuticals, Inc.	—	2.37%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	MDGLMadrigal Pharmaceuticals, Inc.	2.35%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	COGTCogent Biosciences, Inc.	2.27%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	CAPRCapricor Therapeutics, Inc.	—	2.26%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	CORCencora, Inc.	—	2.25%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ALMSAlumis Inc.	—	2.12%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	TVTXTravere Therapeutics, Inc.	2.06%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	GILDGilead Sciences, Inc.	—	1.99%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	JAZZJazz Pharmaceuticals PLC	—	1.92%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	MRNAModerna, Inc.	—	1.90%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	VTRSViatris Inc.	—	1.88%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	DNTHDianthus Therapeutics, Inc.	—	1.80%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	ALHCAlignment Healthcare, Inc.	1.76%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	INCYIncyte Corp.	—	1.71%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ERASErasca, Inc.	—	1.71%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	HROWHarrow, Inc.	1.65%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	PACSPACS Group, Inc.	1.60%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	CGONCG Oncology, Inc.	—	1.55%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	TYRATyra Biosciences, Inc.	—	1.54%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	IMNMImmunome, Inc.	1.53%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	SLSSELLAS Life Sciences Group, Inc.	—	1.50%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	MIRMMirum Pharmaceuticals, Inc.	1.49%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	SYRESpyre Therapeutics, Inc.	—	1.49%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	TWSTTwist Bioscience Corp.	—	1.45%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	LQDALiquidia Corp.	—	1.42%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	BKDBrookdale Senior Living Inc.	—	1.41%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	TSHATaysha Gene Therapies Inc.	1.37%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	ARQTArcutis Biotherapeutics, Inc.	1.34%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	EXELExelixis, Inc.	—	1.33%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	PTCTPTC Therapeutics, Inc.	1.33%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	TERNTerns Pharmaceuticals, Inc.	4.19%	2.86%	−52.7%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	RAPTRAPT Therapeutics, Inc.	1.32%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	EWTXEdgewise Therapeutics, Inc.	—	1.31%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	CYTKCytokinetics, Inc.	—	1.19%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	NUVBNuvation Bio Inc.	1.17%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ELANElanco Animal Health Inc.	—	1.16%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	IDYAIDEAYA Biosciences, Inc.	1.15%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	ATECAlphatec Holdings, Inc.	1.14%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	TARSTarsus Pharmaceuticals, Inc.	1.13%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	DYNDyne Therapeutics, Inc.	—	1.12%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	PCVXVaxcyte, Inc.	—	1.12%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	KRYSKrystal Biotech, Inc.	—	1.10%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ANABAnaptysBio, Inc.	0.68%	1.78%	+99.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	AMRXAmneal Pharmaceuticals, Inc.	1.08%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ELVNEnliven Therapeutics, Inc.	—	1.07%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	KODKodiak Sciences Inc.	0.92%	1.99%	+19.6%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	RCUSArcus Biosciences, Inc.	—	0.94%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	PGENPrecigen, Inc.	0.94%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	STOKStoke Therapeutics, Inc.	1.84%	0.91%	−51.2%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	PAHCPhibro Animal Health Corp.	—	0.90%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	UTHRUnited Therapeutics Corp.	2.56%	3.43%	+16.9%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	GLUEMonte Rosa Therapeutics, Inc.	0.88%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.